In Situ Hybridization Market Research Reveals Strong 11.3% CAGR Outlook Through 2030

The in situ hybridization market is on track for substantial expansion in the coming years, driven by advancements in diagnostic technologies and increasing demand across various medical and research fields. This report provides an overview of the market's expected value, key players, influencing trends, and the primary segments contributing to its growth.

Projected Market Size and Growth Outlook for the In Situ Hybridization Market
The market for in situ hybridization is anticipated to grow rapidly, reaching a valuation of $3.08 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 11.3%. Factors fueling this expansion include the rising need for personalized medicine diagnostics, the growing incorporation of AI-based image analysis, the broadening use of companion diagnostics, increased investments in genomic research, and the expanding application of in situ hybridization techniques in infectious disease detection. Important trends shaping the market's future include a greater adoption of fluorescence-based hybridization methods, higher demand for precision in molecular diagnostics, increased utilization of automated imaging and analysis tools, growth in cancer diagnostics applications, and improved integration of digital pathology technologies.

Download a free sample of the in situ hybridization market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Organizations Driving the In Situ Hybridization Market Forward
Several prominent companies dominate the in situ hybridization market landscape. These include Thermo Fisher Scientific Inc., Bio SB Inc., BioGenex Laboratories, Advanced Cell Diagnostics Inc., Exiqon A/S, Agilent Technologies Inc., F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Merck KGaA, PerkinElmer Inc., Biocare Medical LLC, Genemed Biotechnologies, Danaher Corporation, Leica Biosystems Nussloch GmbH, Bio-Rad Laboratories Inc., Oxford Gene Technology, Qiagen, Bio-Techne Corporation, Cytocell Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Zytomed System GmbH, Akoya Biosciences Inc., Becton dic*kinson and Company (BD), DAKO Systemtechnik und Service GmbH & Co, NanoString Technologies Inc., and Visiopharm A/S.

A significant move occurred in December 2023 when Danaher Corporation acquired Abcam plc for $5.7 billion. This acquisition aims to broaden Danaher's diagnostics and reagent portfolio while enhancing its molecular assay development capabilities by incorporating Abcam's extensive antibody collections, kits, and research reagents. Abcam, based in the UK, is well known for offering high-quality reagents and assay products that support molecular biology workflows, including those that complement in situ hybridization and immunohistochemistry applications.

View the full in situ hybridization market report:
https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Important Trends Positively Influencing Market Growth in In Situ Hybridization
Innovative product development is a major focus for leading companies in the in situ hybridization market. For instance, the introduction of HCR RNA-CISH (Hybridization Chain Reaction RNA Chromogenic in situ Hybridization) technology is helping firms improve market profitability. This advanced technique allows for highly sensitive and high-resolution visualization of RNA molecules in cells and tissues.

In February 2023, Molecular Instruments (MI), a biotech spinout from the California Institute of Technology, launched HCR RNA-CISH kits designed to enhance automated chromogenic in situ hybridization workflows that build on RNAscope technology. These kits offer significantly better performance than existing chromogenic ISH methods, with twice the turnaround speed and half the cost. Additionally, they natively support Immunohistochemistry (IHC) codetection and are compatible with all leading automation platforms, making them attractive tools for laboratories aiming to improve efficiency and accuracy.

Main Segments Driving Expansion in the In Situ Hybridization Market
This market is segmented broadly into the following categories:

1) Product Types: Analytical Instruments, Kits and Reagents, Software and Services
2) Techniques: Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization (CISH)
3) Probes: Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA)
4) Applications: Cancer, Cytogenetics, Developmental Biology, Infectious Diseases
5) End Users: Research and Diagnostic Laboratories, Contract Research Organizations (CROs), Academic Institutes

Within these broader categories, subsegments exist as well:

- Analytical Instruments include Fluorescence Microscopes, Imaging Systems, and Hybridization Systems.
- Kits and Reagents cover Hybridization Kits, Detection Kits, Probes, and Reagents.
- Software and Services encompass Image Analysis Software, Data Management Software, and Consulting and Support Services.

This detailed segmentation highlights the diverse components contributing to the overall in situ hybridization market growth and underscores the varied applications and technological advancements fueling demand worldwide.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.